Precision Fermentation Drives Next-Gen Food Innovation: MycoTechnology Unveils Honey Truffle Sweet Protein, All G Launches Cow-Free Lactoferrin in US

August 2, 2026

foodingredientsfirst.com / Precision Fermentation News / flavorist.com / Vivici / Microbio International

Overview

Precision fermentation is significantly advancing the next-generation food ingredient market. MycoTechnology announced its precision-fermented Zukora Honey Truffle Sweet Protein, 2,000 times sweeter than sugar, at IFT FIRST 2026. All G, in partnership with a top Chinese CDMO, launched its 60,000-liter scale cow-free lactoferrin in the US, with human beta-casein under development. ADM and The EVERY Company also partnered to scale precision-fermented egg protein, while Vivici is scaling lactoferrin production. This trend highlights precision fermentation’s ability to overcome supply constraints for high-value proteins, offering sustainable and consistent alternatives to animal-derived ingredients.

In Depth

Key Findings

Precision fermentation technology is driving a revolutionary shift in the next-generation food ingredient market, with notable progress in supplying high-value proteins and developing sugar alternatives. At IFT FIRST 2026, MycoTechnology unveiled its precision-fermented ‘Zukora Honey Truffle Sweet Protein,’ reportedly 2,000 times sweeter than sugar, capturing significant industry attention. Simultaneously, All G has launched its cow-free lactoferrin in the US market, produced at a 60,000-liter scale through a partnership with a leading Chinese CDMO, addressing critical supply chain challenges. Furthermore, ADM and The EVERY Company have formed a partnership for commercial-scale production of precision-fermented egg protein, and Vivici is actively scaling up lactoferrin production. These developments clearly indicate that precision fermentation is shaping the future of the food industry by offering sustainable and consistent alternatives to animal-derived ingredients.

Technical / Clinical Details

Precision fermentation is a biotechnological process that utilizes specific microorganisms (such as yeast, fungi, or bacteria) to produce targeted proteins, enzymes, or other biomolecules through genetic engineering. Similar to cell culture, this process involves growing microorganisms in bioreactors under controlled conditions, enabling them to efficiently secrete the desired ingredients. For instance, MycoTechnology’s sweet protein is derived from a rare sweet protein discovered in cacao, manufactured via precision fermentation to serve as a sugar alternative without a lingering aftertaste. All G’s lactoferrin, while possessing the same molecular structure as conventional bovine lactoferrin, enables animal-free production. This technology offers the advantages of high purity and consistent quality, alongside reduced risks of allergens and pathogens. In the partnership between ADM and The EVERY Company, ADM will leverage its commercial-scale precision fermentation capabilities to manufacture EVERY’s flagship ingredient, OvoPro (egg protein), addressing sustainability and supply challenges inherent in traditional egg production. Vivici’s efforts are similarly aimed at producing lactoferrin, a valuable bioactive protein historically constrained by limited supply and complex extraction processes, at a commercially viable scale.

Background & Context

The global food system faces a confluence of complex challenges, including population growth, climate change, and increasing environmental awareness. Traditional livestock farming has been criticized for its significant environmental footprint, including greenhouse gas emissions and extensive land and water consumption, leading to a rapid surge in demand for sustainable alternative protein sources. Against this backdrop, precision fermentation is emerging as a pivotal technology that not only provides alternatives to expensive animal-derived ingredients but also enhances supply chain resilience. Sweet proteins, milk proteins (lactoferrin, beta-casein), and egg proteins, among others, have diverse applications in nutritional supplements, functional foods, infant formula, and sports nutrition products, indicating substantial market potential. Strategic partnerships with major CDMOs in the US and China signify that this technology is transitioning from the R&D phase to commercial scale, accelerating innovation within the food industry.

Strategic Significance & Outlook

Precision fermentation technology is poised to fundamentally transform the food industry landscape in the coming years. Further reducing production costs, optimizing scale-up technologies, and enhancing consumer acceptance will be critical challenges for the widespread adoption of this technology. Strategic collaborations between companies are essential for de-risking R&D investments and accelerating the path to commercialization. Moreover, new functional ingredients produced through precision fermentation, such as ‘postbiotics,’ hold the potential to create significant markets amid rising awareness of gut health and overall well-being. The establishment of clear regulatory guidelines will also be crucial for fostering investment and innovation. The evolution of this technology is key to building a more sustainable, nutritious, and animal-friendly food system for the future.

Source: https://www.foodingredientsfirst.com/news/sweet-protein-blends-drive-next-gen-sugar-reduction-at-ift-first-2026.html

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.